Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OpenPMX Software for Nonlinear Mixed-Effect Models in Pharmacometrics: Precision Compared With NONMEM First-Order Conditional Estimation.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Prospective clinical evaluation of the Eleveld pharmacokinetic and pharmacodynamic model of propofol for moderate-to-deep sedation in adults.

European journal of anaesthesiology·2026
Same author

Evaluating Model-Based Extrapolation of Plasma Exposure for Long-Acting Injectable Products: From Single- to Multiple-Dose Trials.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Clinical Pharmacokinetics and Pharmacodynamics of Remimazolam.

Clinical pharmacokinetics·2025
Same author

Development and analysis of a remimazolam pharmacokinetics and pharmacodynamics model with proposed dosing and concentrations for anaesthesia and sedation.

British journal of anaesthesia·2025
Same author

Influence of Remifentanil on the Pharmacokinetics and Pharmacodynamics of Remimazolam in Healthy Volunteers.

Anesthesiology·2025

Related Experiment Video

Updated: Jul 11, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

Simultaneous versus sequential pharmacokinetic-pharmacodynamic population analysis using an iterative two-stage

Johannes H Proost1, Sjouke Schiere, Douglas J Eleveld

  • 1Research Group for Experimental Anesthesiology and Clinical Pharmacology, Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. j.h.proost@rug.nl

Biopharmaceutics & Drug Disposition
|September 12, 2007
PubMed
Summary

An Iterative Two-Stage Bayesian (ITSB) algorithm offers valuable pharmacokinetic-pharmacodynamic (PK-PD) population analysis for rich datasets. However, sequential PK-PD analysis is better suited than simultaneous analysis when pharmacodynamic (PD) models are misspecified.

More Related Videos

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
22:10

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

Related Experiment Videos

Last Updated: Jul 11, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
22:10

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

Area of Science:

  • Pharmacometrics
  • Pharmacokinetics
  • Pharmacodynamics

Background:

  • Population pharmacokinetic-pharmacodynamic (PK-PD) analysis is crucial for understanding drug behavior.
  • Rich datasets with numerous measurements per individual enable advanced analytical approaches.

Purpose of the Study:

  • To develop and evaluate an Iterative Two-Stage Bayesian (ITSB) algorithm for simultaneous PK-PD population analysis.
  • To compare the performance of simultaneous versus sequential PK-PD analysis, and nonparametric PK methods.
  • To investigate the impact of pharmacodynamic (PD) model misspecification on PK-PD analysis.

Main Methods:

  • Development of an Iterative Two-Stage Bayesian (ITSB) algorithm for simultaneous PK-PD analysis.
  • Evaluation using clinical data (rocuronium in anesthetized patients) and Monte Carlo simulations.
  • Comparison of simultaneous PK-PD, sequential PK-PD, and PD analysis with nonparametric PK data.

Main Results:

  • Simultaneous PK-PD analysis yielded slightly more precise population parameter estimates than sequential PK-PD and nonparametric PK methods.
  • In cases of PD model misspecification, simultaneous analysis led to poor PK parameter estimates, whereas sequential PK-PD analysis performed well.
  • ITSB is effective for PK-PD population analysis of rich datasets.

Conclusions:

  • The Iterative Two-Stage Bayesian (ITSB) algorithm is a valuable technique for PK-PD population analysis, particularly with rich datasets.
  • Sequential PK-PD analysis demonstrates superior performance compared to simultaneous analysis when dealing with potential PD model misspecification.